The relationship between plasma amino acid and anemia, prognosis in hemodialysis patients

The relationship between plasma amino acid and anemia, prognosis in hemodialysis patients - The relationship between plasma amino acid and anemia, prognosis in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023287

Enrollment

141

Registered

2016-08-01

Start date

2016-07-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end stage renal disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who enrolled in past clinical trial -Residual renal function in hemodialysis patients-

Exclusion criteria

Exclusion criteria: severe congestive heart failure (New York Heart Association class III or IV) uncontrolled hypertension (defined as a pre-dialysis diastolic blood pressure >110 mm Hg) acute malignancy major surgery within the previous 6 months active bleeding, need for erythrocyte transfusion within 12 weeks before the study systemic inflammatory disease and/or C-reactive protein levels >3 mg/dL

Design outcomes

Primary

Measure	Time frame
plasma amino acid level complete blood count cardiovascular disease death - 4 years all cause death - 4 years	—

Countries

Japan

Contacts

Public ContactTatsuo Hashimoto

Yokohama city university hospital Nephrology/Hypertension

tatuhashi@hotmail.com045-787-2800

Outcome results